Plegridy (Peginterferon beta-1a): Extended-Dosing Interferon for MS

By Dr. Emily Hanover

Plegridy (Peginterferon beta-1a): Extended-Dosing Interferon for MS is a comprehensive guide to one of the most innovative disease-modifying therapies for multiple sclerosis (MS). Written by Dr. Emily Hanover, this book provides a detailed exploration of Plegridy's pharmacology, clinical efficacy, safety profile, and its role in MS management.

Designed for patients, caregivers, and healthcare professionals, this book breaks down complex medical concepts into clear and accessible information. It covers the history of MS treatments, the science behind interferon-based therapies, and the advantages of Plegridy's extended-dosing regimen. Readers will gain insights into its mechanism of action, dosing guidelines, side effect management, and comparisons with other disease-modifying treatments.

With an emphasis on patient-centered care, this book also discusses the impact of Plegridy on quality of life, adherence strategies, and future trends in MS treatment. Whether you are considering Plegridy as a treatment option or seeking a deeper understanding of MS therapies, this authoritative resource offers valuable knowledge to support informed decision-making.

• Format: Paperback
• Language: English
• ISBN: B0F143HWGQ
• ISBN13: 9798313705125
• Release Date: March 2025
• Publisher: Independently Published
• Length: 196 Pages
• Weight: 0.59 lbs.
• Dimensions: 0.4" x 6.0" x 9.0"